Cargando…

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

BACKGROUND/AIMS: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona Clinic Liver Cancer (BCLC) staging system. However, the crit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jun Young, Sinn, Dong Hyun, Gwak, Geum-Youn, Choi, Gyu-Seong, Saleh, Aldosri Meshal, Joh, Jae-Won, Cho, Sung Ki, Shin, Sung Wook, Carriere, Keumhee Chough, Ahn, Joong Hyun, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946408/ https://www.ncbi.nlm.nih.gov/pubmed/27377909 http://dx.doi.org/10.3350/cmh.2016.0015

Ejemplares similares

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
por: Kim, Jihye, et al.
Publicado: (2019)

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
por: Yu, Jeong Il, et al.
Publicado: (2017)

Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
por: Sohn, Won, et al.
Publicado: (2014)

Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria
por: Oh, Joo Hyun, et al.
Publicado: (2020)

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
por: Goh, Myung Ji, et al.
Publicado: (2020)

Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation
por: Kim, Sue Jin, et al.
Publicado: (2009)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2020)

Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma
por: Kim, Sang Won, et al.
Publicado: (2014)

Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
por: Chen, Shiguang, et al.
Publicado: (2018)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
por: Ahn, Jem Ma, et al.
Publicado: (2015)

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Jae Seung, et al.
Publicado: (2021)

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
por: Mei, Jie, et al.
Publicado: (2019)

Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma
por: Wu, Juan, et al.
Publicado: (2023)

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
por: Kim, Jihye, et al.
Publicado: (2020)

Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea
por: Kim, Jihye, et al.
Publicado: (2020)

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
por: Kim, Jung Hee, et al.
Publicado: (2017)

Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea
por: Song, Byeong Geun, et al.
Publicado: (2022)

Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea
por: Kwon, Tae Jin, et al.
Publicado: (2021)

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

Predictive imaging for tumor response to drug-eluting microsphere transarterial chemoembolization in patients with BCLC-C advanced hepatocellular carcinoma
por: Chang, Kai-Hsiang, et al.
Publicado: (2019)

A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
por: Lin, Huapeng, et al.
Publicado: (2021)

Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
por: Kang, Ja Young, et al.
Publicado: (2010)

Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
por: Lee, Keol, et al.
Publicado: (2016)

Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
por: Sinn, Dong Hyun, et al.
Publicado: (2015)

Analysis of mixed data: methods & applications
por: de Leon, Alexander R, et al.
Publicado: (2013)

Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Sang-Geun, et al.
Publicado: (2022)

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Kim, Jung Hee, et al.
Publicado: (2016)

Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
por: Sinn, Dong Hyun, et al.
Publicado: (2014)

Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study
por: Kim, Jung Hee, et al.
Publicado: (2016)

Correction: Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
por: Wu, Fei-Xiang, et al.
Publicado: (2017)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Tampaki, Maria, et al.
Publicado: (2020)

The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience
por: Yi, Peng-Sheng, et al.
Publicado: (2022)

Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
por: Cho, Ju-Yeon, et al.
Publicado: (2017)

Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
por: Goh, Myung Ji, et al.
Publicado: (2022)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
por: Song, Myeong Jun, et al.
Publicado: (2016)

Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study
por: Xia, Wei-Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jti68c1tqcv8gseap4sn9bq98t